VivoSeq
Other

Sunburn

9

Pipeline Programs

0

Active Trials

7

Companies Involved

Sunburn is an early-stage landscape with 9 programs across 7 companies. The most active players are Neurim Pharmaceuticals Ltd., Sephoris Pharmaceuticals LLC, Cerimon Pharmaceuticals. 5 therapies are approved with 2 more in late-stage development.

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

0/100

Mech. Concentration

33/100

Completion Rate

75/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

9

clinical trials

Unknown status5 · 56%
Completed3 · 33%
Terminated1 · 11%

Trial Activity

9 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)